Drug Profile
CPC 402
Latest Information Update: 17 Apr 2001
Price :
$50
*
At a glance
- Originator Questcor Pharmaceuticals
- Class Ischaemic heart disorder therapies; Neuroprotectants; Vasodilators
- Mechanism of Action Adenosine deaminase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Myocardial ischaemia; Stroke; Supraventricular tachycardia
Most Recent Events
- 17 Apr 2001 Discontinued-Preclinical for Myocardial ischaemia in USA (Unknown route)
- 17 Apr 2001 Discontinued-Preclinical for Stroke in USA (Unknown route)
- 17 Apr 2001 Discontinued-Preclinical for Supraventricular tachycardia in USA (Unknown route)